On and off-road motorcycles, fuel dragsters, hydroplane boats, sail boats, power boats, bicycles, and now cars: J.R. Smith has raced all of these. After a cancer diagnosis in 2019, he...
Advancing detection of prostate cancer, a new imaging drug targets PSMA—a protein marking cancer cells—helping physicians identify disease earlier and guiding patients toward timely, confident treatment decisions.
Firefighters face hidden cancer risks long after the fire is out. A new comprehensive cancer screening initiative is helping doctors find cancer earlier and better understand occupational risk factors.
Prostate cancer is the most common cancer to affect American men, besides skin cancer. Skyler Johnson, MD, describes what symptoms to look for and why screenings are so important.
After an unexpected dual cancer diagnosis, Walter received cutting-edge treatment at Huntsman Cancer Institute. He now gives back through Huntsman Cancer Foundation SportsFest, turning his survival into hope for others.
After a prostate cancer diagnosis during the pandemic, Dennis Freire sought care in Utah. Through trust, shared decision-making, and a strong bond with his doctor, he continues living well.
Two Huntsman Cancer Institute researchers are recognized with endowed chairs. Endowed chairs are created through philanthropy and honor accomplishments in research.
A virtual support group provides a way for members to openly share struggles, find emotional support, and learn coping techniques from experts, creating a unique brotherhood.
Could the future of prostate cancer rehabilitation be in virtual reality? A trial at Huntsman Cancer Institute explores how telerehabilitation can help rural and frontier patients.
Utah TV icon Bill Gephardt says “shared decision making,” a process where specialists help patients pick the best treatment option, empowered him during his prostate cancer treatment.
In 2011, Lowry Bushnell was given a life-changing diagnosis and just years to live. After meeting with Dr. Tward, his hope and future were restored. Now, the cancer is gone...
The latest advances in cancer research from Huntsman Cancer Institute include a new prostate cancer treatment, a method to predict aggressive breast cancer, and microbiome links to melanoma immunotherapy response.
A global study of a combination drug therapy, led by an investigator at Huntsman Cancer Institute, has shown improved overall survival rates for metastatic prostate cancer compared to standard treatments.
Explore prostate cancer treatment options like surgery, radiation, and hormone therapy. Learn how to choose the best approach with your healthcare provider’s guidance and support.
The chance of getting prostate cancer increases with age, but genetics can also be a risk factor. Huntsman Cancer Institute genetic counselor Sam Beck answers questions about prostate cancer.
